Annual Drug Patent Expirations for COMBIGAN
Combigan is a drug marketed by Allergan and is included in one NDA. It is available from two suppliers. There are eleven patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for COMBIGAN.
This drug has twenty-six patent family members in nineteen countries.
The generic ingredient in COMBIGAN is brimonidine tartrate; timolol maleate. Two suppliers are listed for this compound. Additional details are available on the brimonidine tartrate; timolol maleate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com